|
English |
ÖÐÎÄ |
English |
ÖÐÎÄ |
|
absorption |
ÎüÊÕ£¬ÎüÊÕ×÷Óà |
kanamycin |
¿¨ÄÇÃ¹ËØ |
|
abstinence syndrome |
½ä¶ÏÖ¢×´ |
latent period |
DZ·üÆÚ |
|
acetaminophen |
´×°±·Ó |
laxative |
кҩ |
|
acute reaction |
¼±ÐÔ·´Ó¦ |
lethal dose |
ÖÂËÀÁ¿ |
|
addiction |
³Éñ«ÐÔ |
levodopa |
×óÐý¶à°Í |
|
adrenergic drug |
ÉöÉÏÏÙËØÒ© |
liability for abuse |
ÀÄÓÃÇãÏò |
|
adrenoceptor |
ÉöÉÏÏÙÊÜÌå |
lidocaine (xylocaine) |
Àû¶à¿¨Òò |
|
adrenoceptor blocking drug |
ÉöÉÏÏÙËØÊÜÌå×è¶ÏÒ© |
ligand |
ÅäÌå |
|
adrenocortical hormone |
ÉöÉÏÏÙÆ¤Öʼ¤ËØ |
lincomycin |
ÁÖ¿ÉÃ¹ËØ |
|
adrenomimetic drug |
ÄâÉöÉÏÏÙËØÒ© |
lithium carbonate |
̼Ëáï® |
|
affinity |
Ç׺ÍÁ¦ |
loading dose |
¸ººÉ¼ÁÁ¿ |
|
after effect |
ºóÒÅЧӦ |
lobeline |
ɽ¹£²Ë¼î |
|
agent |
Ò©¼Á |
local anaesthetics |
¾ÖÂéÒ© |
|
agonist |
¼¤¶¯¼Á£¬Ð˷ܼÁ£¬Ö÷¶¯¼¡ |
magnesium sulfate |
ÁòËáþ |
|
aldosterone |
È©¹Ìͪ |
margin of safety |
°²È«·¶Î§ |
|
allergy |
±ä̬·´Ó¦ |
mechanism of action |
×÷ÓûúÖÆ |
|
aminoglycosides |
°±»ùÌÇß°Àà |
meclofenoxate |
ÂÈõ¥ÐÑ |
|
amitriptyline |
°¢ÃÜÌæÁÖ |
median effective dose |
°ëÊýÓÐЧÁ¿ |
|
Amobarbital (amytal) |
ÒìÎì°Í±ÈÍ× |
meperidine (pethidine) |
ßßÌæà¤ |
|
amoxicillin |
ôǰ±ÜÐÇàÃ¹ËØ(°¢ÄªÎ÷ÁÖ) |
metabolism |
г´úл |
|
amphotericin B |
¶þÐÔÃ¹ËØB |
metabolite |
´úлÎï |
|
ampicillin |
°±ÜÐÇàÃ¹ËØ(°¢±ÈÎ÷ÁÖ) |
metaraminol |
¼äôǰ· |
|
amrinone |
°·ßÁͪ |
metformin |
¶þ¼×Ë«ëÒ |
|
anaesthetic ether |
Âé×íÒÒÃÑ |
methadone |
ÃÀɳͪ |
|
analgesia |
ÕòÍ´ |
methimazole |
¼×Áòßäßò |
|
analgesics |
ÕòÍ´Ò© |
methyldopa |
¼×»ù¶à°Í |
|
angiotensin converting |
Ѫ¹Ü½ôÕÅËØ×ª»» |
methylphenidate |
ßß´×¼×õ¥ |
|
anisodamine |
ɽݹÝмî |
metoprolol |
ÃÀÍÐÂå¶û |
|
antagonist |
Þ׿¹¼Á |
metronidazole |
¼×Ïõßò(ÃðµÎÁé) |
|
antiadrenergic drug |
¿¹ÉöÉÏÏÙËØ |
mexiletine |
ÃÀÎ÷ÂÉ |
|
antianginal drug |
¿¹ÐĽÊÍ´Ò© |
minimal effective dose |
×îСÓÐЧÁ¿ |
|
antianxiety |
¿¹½¹ÂÇ |
minimal toxic dose |
×îСÖж¾Á¿ |
|
antiasthmatic drug |
¿¹´Ò© |
molecular pharmacology |
·Ö×ÓÒ©Àíѧ |
|
antibiotics |
¿¹ÉúËØ |
monoamine oxidase (MAO) |
µ¥°·Ñõ»¯Ã¸ |
|
anticarcinoma drug |
¿¹Ö×ÁöÒ© |
morphine |
Âð·È |
|
anticholinergic drug |
¿¹µ¨¼îÒ© |
muscarine |
¶¾Þ¦¼î |
|
anticholinesterase drug |
¿¹µ¨¼îõ¥Ã¸Ò© |
nalorphine |
±ûÏ©Âð·È |
|
anticoagulant |
¿¹ÄýѪҩ |
naloxone |
ÄÉÂåͪ |
|
anticonvulsive drug |
¿¹¾ªØÊÒ© |
negative chronotropic action |
¸ºÐÔ±äʱЧӦ |
|
antidiabetic drug |
¿¹ÌÇÄò²¡Ò© |
Neostigmine |
ÐÂ˹µÄÃ÷ |
|
antidiarrheal agent |
ֹкҩ |
neuroleptanalgesia |
Éñ¾°²¶¨ÕòÍ´Êõ |
|
antiepileptic drug |
¿¹ñ²ðïÒ© |
neuroleptic drug |
Éñ¾°²¶¨Ò© |
|
antihypertensive drug |
¿¹¸ßѪѹҩ |
neuromuscular blocking drug |
Éñ¾¼¡Èâ×è¶ÏÒ© |
|
antiinflammatory agent |
¿¹Ñ×Ò© |
neuropharmacology |
Éñ¾Ò©Àíѧ |
|
antimalarial drug |
¿¹Å±Ò© |
nicardipine |
ÄῨµØÆ½ |
|
antimanic drug |
¿¹Ôê¿ñÒ© |
nicotine |
Ñ̼î |
|
antituberculosis drug |
¿¹½áºËÒ© |
nifidipine |
Ïõ±½µØÆ½ |
|
artemisinin |
ÇàÝïËØ |
nimodipine |
ÄáĪµØÆ½ |
|
aspirin |
°¢Ë¹Æ¥ÁÖ |
nitrendipine |
ÄáȺµØÆ½ |
|
atenolol |
°¢ÌæÂå¶û |
nitroglycerin |
ÏõËá¸ÊÓÍ |
|
atropine |
°¢ÍÐÆ· |
nitrous oxide |
Ò»Ñõ»¯Ñǵª(Ð¦Æø) |
|
barbiturates |
°Í±ÈÍ×Àà |
noradrenaline (norepinephrine) |
È¥¼×ÉöÉÏÏÙËØ |
|
basis pharmacology |
»ù´¡Ò©Àíѧ |
novocaine |
Å«·ð¿¨Òò |
|
benzodiazepines |
±½¶þµª |
occupation theory |
Õ¼Áìѧ˵ |
|
biguanides |
Ë«ëÒÀàÒ©Îï |
one compartment model |
Ò»ÊÒÄ£ÐÍ |
|
bioavailability |
ÉúÎïÀûÓÃ¶È |
oxidation |
Ñõ»¯ |
|
biochemical pharmacology |
Éú»¯Ò©Àíѧ |
parenteral route |
·Ç³¦µÀ;¾¶ |
|
biotransformation |
ÉúÎïת»¯ |
partial agonist |
²¿·Ö¼¤¶¯¼Á |
|
bretylium |
äåÜа· |
partial antagonist |
²¿·ÖÞ׿¹¼Á |
|
bromocriptine |
äåÒþͤ |
peak time |
·åʱ¼ä |
|
bumetanide |
²¼ÃÀËûÄᣬ¶¡±½ÑõËá |
penicillin G (benzylpenicillin) |
ÇàÃ¹ËØG(ÜÐÇàÃ¹ËØ) |
|
caffeine |
¿§·ÈÒò |
pentazocine |
ÕòÍ´ÐÂ |
|
calcium antagonists |
¸ÆÞ׿¹Ò© |
per os |
¿Ú·þ |
|
carbamazepine |
¿¨°ÍÎ÷ƽ |
perphenazine |
·ÜÄ˾² |
|
carbenicillin |
ôÈÜÐÇàÃ¹ËØ |
persistent period |
³ÖÐøÊ±¼ä |
|
carbidopa |
¿¨±È¶à°Í |
pharmacodynamics |
Ò©£¨ÎЧ£¨Ó¦£©¶¯Á¦Ñ§ |
|
carbimazole |
¿¨±ÈÂíßò |
pharmacokinetics |
Ò©£¨Î´ú£¨Ð»£©¶¯Á¦Ñ§ |
|
carcinogenicity |
Ö°©Á¦ |
pharmacology |
Ò©Àíѧ |
|
cardiac glycoside |
Ç¿ÐÄß° |
pharmacology |
Ò©Àíѧ |
|
cardiovascular pharmacology |
ÐÄѪ¹ÜÒ©Àíѧ |
pharmacopeia |
񩵊 |
|
carrier |
Я´øÕߣ¬ÔØÌå£¬ÔØÁ÷×Ó£¬´ø³æÕß |
phenobarbital (luminal) |
±½°Í±ÈÍ×(³Ã×ÄÇ) |
|
catecholamine |
¶ù²è·Ó°· |
phenolphthalein |
·Ó̪ |
|
central stimulant |
ÖÐÊàÐË·ÜÒ© |
phenothiazines |
·ÔàçàºÀà |
|
depression |
ÒÖÖÆ£¬¼õѹ |
phenoxybenzamine |
·ÓÜÐÃ÷ |
|
detoxification |
½â¶¾£¬½â¶¾×÷Óà |
phentolamine |
·ÓÍ×ÀÃ÷ |
|
dexamethasone |
µØÈûÃ×ËÉ |
physostigmine |
¶¾±â¶¹¼î |
|
diazepam |
°²¶¨ |
pilocarpine |
ë¹ûÔÆÏã¼î |
|
diazoxide |
¶þµªàº |
pindolol |
ßÅßáÂå¶û |
|
dicaine |
µÄ¿¨Òò |
placebo |
°²Î¿¼Á |
|
dicoumarol |
Ë«Ïã¶¹ËØ |
placental barrier |
Ì¥ÅÌÆÁÕÏ |
|
digestants |
ÖúÏû»¯Ò© |
polymyxins |
¶àÕ³¾úËØÀà |
|
digitalis |
ÑóµØ»Æ |
positive inotropic action |
ÕýÐÔ±äÁ¦Ð§Ó¦ |
|
digitoxin |
ÑóµØ»Æ¶¾ß° |
pralidoxime chloride |
ÂȽâÁ×¶¨ |
|
digoxin |
µØ¸ßÐÁ |
pralidoxime iodide |
µâ½âÁ×¶¨ |
|
diphenhydromine benadryl |
±½º£ÀÃ÷ |
prednisolone |
ÆÃÄáËÉÁú |
|
diuretic |
ÀûÄò¼Á |
prednisone |
ÆÃÄáËÉ |
|
dobutamine |
¶à°Í·Ó¶¡°· |
probenecid |
±û»ÇÊæ |
|
dosage |
¼ÁÁ¿ |
procainamide |
ÆÕ³¿¨Òò°· |
|
droperidol |
·úßßÀû¶à |
promethazine |
Òì±ûຠ|
|
drug abuse |
Ò©ÎïÀÄÓà |
propafenone |
ÆÕÂÞÅÁͪ |
|
drug dependence |
Ò©ÎïÒÀÀµÐÔ |
propranolol |
Ðĵð² |
|
drug enzyme |
ҩø |
propylthiouracil |
±û»ùÁòÑõà×ठ|
|
drug metabolism |
Ò©Îï´úл |
protein binding |
µ°°×½áºÏ |
|
efferent nervous system |
´«³öÉñ¾ÏµÍ³ |
psychopharmacology |
¾«ÉñÒ©Àíѧ |
|
efficacy |
ЧÄÜ |
psychotroptic drug |
¿¹¾«Éñ²¡Ò© |
|
elimination rate constant |
Çå³ýËÙÂʳ£Êý |
pyrimethamine |
ÒÒ°·à×ठ|
|
ephedrine |
Â黯¼î |
quinidine |
¿üÄá¶¡ |
|
ethambutol |
ÒÒ°·¶¡´¼ |
quinine |
¿üÄþ |
|
ethosuximide |
ÒÒçú°· |
quinolones |
àŵͪÀà |
|
etiological treatment |
²¡ÒòÖÎÁÆ |
ranitidine |
À×ÄáÌæ¶¡ |
|
euphoria |
ÐÀ¿ìÖ¢ |
receptor |
ÊÜÌå |
|
excitation |
¼¤·¢£¬ÐË·Ü |
rectum |
Ö±³¦ |
|
excretion |
·ÖÃÚ£¬ÅÅй |
replacement therapy |
Ìæ´úÖÎÁÆ |
|
fentanyl |
·ÒÌ«Äá |
reserpine |
ÀûѪƽ |
|
first pass effect |
Ê×¹ýЧӦ |
residual period |
²ÐÁôÆÚ |
|
first pass elimination |
Ê×¹ýÏû³ý |
resistance |
ÄÍÒ©ÐÔ£¬×èÁ¦ |
|
fluphenazine |
·ú·ÜÄ˾² |
salbutamol |
ɳ¶¡°·´¼ |
|
folic acid |
Ò¶Ëá |
scopolamine |
¶«Ý¹Ýмî |
|
furazolidone |
ß»à«ßòͪ |
secobarbital (seconal) |
˾¿É°Í±ÈÍ×(ËÙ¿ÉÃß) |
|
furosemide |
ËÙÄò |
secondary reaction |
¼Ì·¢·´Ó¦ |
|
ganglionic blocking drug |
Éñ¾½Ú×è¶ÏÒ© |
sedatives |
Õò¾²Ò© |
|
gentamicin |
Çì´óÃ¹ËØ |
selectivity |
Ñ¡ÔñÐÔ |
|
glucocorticoid |
ÌÇÆ¤Öʼ¤ËØ |
side reaction |
¸±×÷Óà |
|
gray baby syndrome |
»ÒÓ¤×ÛºÏÕ÷ |
site of metabolism |
´úл²¿Î» |
|
Guanethidine |
ëÒÒÒठ|
skeletal muscular relaxant |
¹Ç÷À¼¡ËɳÚÒ© |
|
habituation |
ϰ¹ßÐÔ |
sodium cromoglycate |
É«¸ÊËá¶þÄÆ |
|
halothane |
·úÍé |
sodium nitroprusside |
ÏõÆÕÄÆ |
|
hepatoenteral circulation |
¸Î³¦Ñ»· |
sodium thiopental |
ÁòÅçÍ×ÄÆ |
|
heroin |
º£ÂåÒò |
sodium valproate |
±ûÎìËáÄÆ |
|
histamine |
×é°· |
spiramycin |
ÂÝÐýÃ¹ËØ |
|
Homatropine |
ºóÂíÍÐÆ· |
stimulation |
´Ì¼¤ |
|
hydrochlorothiazide |
ÇâÂÈàçຠ|
streptokinase |
Á´¼¤Ã¸ |
|
hydrocortisone |
Ç⻯¿ÉµÄËÉ |
structure activity relationship |
¹¹Ð§¹ØÏµ |
|
hydrolazine |
ëÂÇüຠ|
succinylcholine |
çúç굨¼î |
|
hydroprednisone |
Ç⻯ÆÃÄáËÉ |
sulfonylureas |
»Çõ£ëåÀàÒ©Îï |
|
hyperreaction |
¸ßÃôÐÔ |
supplement therapy |
²¹³äÖÎÁÆ |
|
hypersensitive reaction |
¹ýÃô·´Ó¦ |
symptomatic treatment |
¶ÔÖ¢ÖÎÁÆ |
|
Ibuprofen |
²¼Âå·Ò |
terbutaline |
ÌØ²¼ËûÁÖ |
|
idiosyncratic reaction |
ÌØÒìÖÊ·´Ó¦ |
terramycin |
ÍÁÃ¹ËØ |
|
imipramine |
±ûßäຠ|
tetracaine |
¶¡¿¨Òò |
|
immunopharmacology |
ÃâÒßÒ©Àíѧ |
tetracycline |
ËÄ»·ËØ |
|
immunopotentiating drug |
ÃâÒßÔöǿҩ |
therapeutic action |
ÖÎÁÆ×÷Óà |
|
immunosuppressive drug |
ÃâÒßÒÖÖÆÒ© |
therapeutic dose |
ÖÎÁÆÁ¿ |
|
indomethacin |
ßÅßáÃÀÐÁ£¬ÏûÑ×Í´ |
therapeutic index |
ÖÎÁÆÖ¸Êý |
|
inhalation |
ÎüÈë |
thiazides |
àçàºÀà |
|
inhibition |
ÒÖÖÆ |
threshold dose |
ãмÁÁ¿ |
|
insulin |
ÒȵºËØ |
tolbutamide |
¼×»Ç¶¡ëå |
|
intrinsic activity |
ÄÚÔÚ»îÐÔ |
tolerance |
ÄÍÊÜ |
|
iodide |
µâ»¯Îï |
|
|